Who
Roderick Wong
Director and 10% owner
Company insider
Files Form 4 as: 10% owner, Yarrow Bioscience; Director and 10% owner and Other, Rocket Pharmaceuticals; Director and 10% owner, Allurion Technologies; Chief Executive Officer, Orchestra BioMed Holdings; 10% owner, Milestone Pharmaceuticals; 10% owner, Renovacor; MP and CIO, Avidity Biosciences; 10% owner, Prometheus Biosciences.
In numbers
- Trades disclosed
- 113
- Buys
- 55
- Sells
- 2
- Bought
- $99.9M
- Sold
- $29.4M
- Companies
- 13
- Companies where not an officer
- 10
- First trade
- 30 Jun 2010
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | YARW Yarrow Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code J | —133,290 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | YARW Yarrow BioscienceBiotechnology | SEC FORM 4 Code J | —133,290 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —27,832 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,960 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,960 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —27,832 at $0.00 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —991,544 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —767,848 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —96,896 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code A | $1.7M991,544 at $1.67 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code A | $1.3M767,848 at $1.67 | filing |
| 12 Nov 2025filed 13 Nov 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code A | $162K96,896 at $1.67 | filing |
| 18 Jun 2025filed 18 Jul 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Jun 2025filed 18 Jul 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —17,667 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $149K49,900 at $2.99 | filing |
| 16 Apr 2025filed 17 Apr 2025 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | — | filing |
| 16 Apr 2025filed 17 Apr 2025 | Allurion Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code C | — | filing |
| 16 Apr 2025filed 17 Apr 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code C | $2.8M822,722 at $3.35 | filing |
| 16 Apr 2025filed 17 Apr 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code C | $2.1M631,954 at $3.35 | filing |
| 16 Apr 2025filed 17 Apr 2025 | Allurion TechnologiesMedical Devices | SEC FORM 4 Code C | $127K37,863 at $3.35 | filing |
News
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology ConferencesMIST · manilatimes.net · 19 Oct 2026Head-To-Head Analysis: Milestone Pharmaceuticals (NASDAQ:MIST) & Bristol Myers Squibb (NYSE:BMY)MIST · themarketsdaily.com · 15 Oct 2026TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026Immunovant (NASDAQ:IMVT) Insider Tuyl Christopher Van Sells 1,327 Shares of Company StockIMVT · themarketsdaily.com · 10 Oct 2026Immunovant (NASDAQ:IMVT) Stock: Insider Jay Stout Sells 3,809 SharesIMVT · themarketsdaily.com · 9 Oct 2026Immunovant (NASDAQ:IMVT) CEO Sells $119,589.66 in StockIMVT · themarketsdaily.com · 8 Oct 2026Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facilityRCKT · proactiveinvestors.com · 7 Oct 2026
0 headlines in the last 90 days name Roderick Wong; 7 articles from the last 14 days about the 6 companies they traded most, at most three about any one of them.